Genomic analysis with patients in mind
The easy-to-use, end-to-end genomic analysis platform for clinical environments
Introducing the most advanced platform for clinical genomic analysis…
State-of-the-art bioinformatic tools that identify complex genomic events overlooked by standard bioinformatic pipelines
Increase your team’s productivity
End-to-end germline and somatic analysis solution that manages the entire process from raw data to the clinical report
Meet quality and compliance goals
Tools to help you meet your quality control and regulatory compliance goals with support for your team in their efforts
Keep your data safe and accessible
Scalable and secure architecture that simplifies data management and meets your security and confidentiality requirements
An integrated platform for all your genomic analysis needs
Perform all your genomic analyses on a unified, easy-to-use, secure platform that meets all major regulatory requirements
We support you from laboratory certification to daily operations
Our team of expert biologists and bioinformaticians provides world-class support to get your laboratory up and running and to ensure that your team gets the help it needs on a day-to- day basis. We have a dedicated program to help your team secure and maintain your laboratory certification. Once you are up and running, our support staff will work with your team to answer questions that crop up during routine analysis.
It’s very nice to work with SeqOne, I’d never go back to the way I was working before. I have more confidence in the accuracy of my diagnoses and can deliver them much faster.
CHU Reims, France
SeqOne is always available to listen and help solve my issues, collaborating with us to deliver practical solutions. This makes SeqOne, in my experience, the best bioinformatic solution on the market.
CHU Montpellier, France
A passion for detail: challenging variants
We are passionate about creating bioinformatic solutions that target hard-to-detect variants such as MNVs, Alu elements and mid-sized deletions. These challenging variants are important because research continues to discover ways in which they impact patient health. Our custom bioinformatic modules complement the industry-standard bioinformatic tools, making it possible to detect important variants that would otherwise be undetected.
SeqOne regularly publishes and shares many of its research results via the open source community.
The vision uniting the SeqOne team is a desire to improve patient outcomes with improved genomic analysis. We use significant resources on research and development to ensure that our platform offers the most effective, easy-to-use solution.
This ambitious program is driven by a team of experts covering all aspects of medical genomics; from clinicians, bioinformaticians, biologists and information technology specialists to experts in algorithmics, artificial intelligence, security and big data.
17 March 2023
SeqOne Genomics appoints Hervé Pouzoullic as Chief Commercial Officer
A seasoned leader in the pharmaceutical and diagnostics industry, specialized in structuring international healthcare sales joins the team to accelerate international expansion Montpellier, March 14 [...]
22 February 2023
SeqOne’s new clinically validated HRD test reduces the number of inconclusive results to improve the prescription of targeted treatments for ovarian cancer patients
The Homologous Recombination Deficiency (HRD) biomarker identifies ovarian cancer patients likely to respond to PARP inhibitors. SeqOne’s test simplifies the deployment of this test while [...]
9 February 2023
SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times
Montpellier, February 9th, 2023: SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving [...]
21 October 2022
Michael Blum joins SeqOne Genomics to head the company’s Research and Development
Renowned specialist in healthcare data science, he will focus on developing A.I. driven genomic analysis solutions to facilitate personalised medicine in oncology and rare diseases [...]